Clinical Trials Browser

Phase 2 × Unknown × HER2-positive Metastatic Breast Cancer × Clear all

NCT05042791 2024-02-09

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Phase 2 Unknown

HER2-positive Metastatic Breast Cancer